Enforcement record

Recommendation disclosure naming 欧州ビジネス協会(EBC)

欧州ビジネス協会(EBC) (Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices)

This page records one action from a Japanese government disclosure, including the published name, governing law, authority, action details, and official source.

Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical DevicesMinistry of Health, Labour and WelfareGovernment disclosure14 September 2023

Action type

Recommendation

Law

Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices

Authority

Ministry of Health, Labour and Welfare

Action date

14 September 2023

Current page: Enforcement record

This screen focuses on one disclosed action: the published name, governing law, authority, facts, source status, and review evidence.

Free report

Save the disclosure record naming 欧州ビジネス協会(EBC)

Includes the published name, regulator, governing law, source links, archive status, and reviewer note fields for internal due-diligence files.

Preserved evidence by Kiroku

Review the preserved source for 欧州ビジネス協会(EBC)

Open the preserved public source with its capture time, original artifact, available verification data, and downloadable evidence pack.

Open preserved source and evidence pack
For developers: JSON integration details

You do not need this for normal browsing. Use it only when integrating this enforcement record into an internal tool or AI workflow.

/api/v1/enforcements?company=%E6%AC%A7%E5%B7%9E%E3%83%93%E3%82%B8%E3%83%8D%E3%82%B9%E5%8D%94%E4%BC%9A%EF%BC%88EBC%EF%BC%89&limit=10

Action summary

Company
欧州ビジネス協会(EBC)Japanese only
Original: 欧州ビジネス協会(EBC)
Governing law
Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices
薬機法
Action type
Recommendation
勧告
Action date
14 September 2023
Issuing authority
Ministry of Health, Labour and Welfare
厚生労働省
Industry context
医療機器国際規制

Violation

Machine-translated summary — verify against original

Exchange of opinions regarding the promotion of international integration and the referencing of countries.

Show original Japanese text

国際整合の推進とリファレンスカントリー化に関する意見交換

Compliance context

Medium

A regulator issued a recommendation or formal request for corrective action.

Health product law covering pharmaceuticals, medical devices, cosmetics, quasi-drugs, labeling, and advertising.

Review the facts and follow-up status. This is usually less severe than a suspension or revocation, but still a public enforcement signal.

This context is an operational aid for review workflows, not a credit opinion or legal conclusion.

Evidence pack

Original Ministry of Health, Labour and Welfare source (Japanese)Open preserved source and evidence pack
Extracted at
2026-04-25T00:26:45.964+00:00
Evidence checked
2026-04-25T00:26:45.964+00:00
Archive captured
2026-06-14T06:33:43.074199+00:00
Show audit JSON
{
  "record": {
    "id": "1cc522d5-a205-4634-a298-99ba9b914fd1",
    "url": "https://regbase.jp/en/enforcement/yakkiho-ou-zhou-bizinesuxie-huiebc-20230914",
    "company_name_original": "欧州ビジネス協会(EBC)",
    "company_name_registry": null,
    "corporate_number": null,
    "law": {
      "ja": "薬機法",
      "en": "Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices"
    },
    "action_type": {
      "ja": "勧告",
      "en": "Recommendation"
    },
    "authority": {
      "ja": "厚生労働省",
      "en": "Ministry of Health, Labour and Welfare"
    }
  },
  "entity_match": {
    "status": "unresolved",
    "confidence": 60,
    "method": "extracted_japanese_name",
    "method_label": "Company name extracted from the Japanese public disclosure",
    "notes": "The linked company profile has not been verified under the current identity policy."
  },
  "review": {
    "status": "unreviewed",
    "label": "Machine extracted"
  },
  "compliance_context": {
    "severity": "Medium",
    "actionMeaning": "A regulator issued a recommendation or formal request for corrective action.",
    "practicalNote": "Review the facts and follow-up status. This is usually less severe than a suspension or revocation, but still a public enforcement signal.",
    "lawContext": "Health product law covering pharmaceuticals, medical devices, cosmetics, quasi-drugs, labeling, and advertising."
  },
  "evidence": {
    "recordUrl": "https://regbase.jp/en/enforcement/yakkiho-ou-zhou-bizinesuxie-huiebc-20230914",
    "officialSourceUrl": "https://www.mhlw.go.jp/stf/newpage_35771.html",
    "officialDocumentUrl": null,
    "archiveUrl": "https://kiroku.today/a/7547e0e12adenpzu",
    "archivedSourceUrl": "https://www.mhlw.go.jp/stf/newpage_35771.html",
    "archiveCapturedAt": "2026-06-14T06:33:43.074199+00:00",
    "extractedAt": "2026-04-25T00:26:45.964+00:00",
    "translatedAt": "2026-05-01T07:14:39.633+00:00",
    "evidenceCheckedAt": "2026-04-25T00:26:45.964+00:00",
    "generatedAt": "2026-08-04T15:30:38.558Z"
  },
  "limitations": [
    "RegBase aggregates public Japanese government disclosures and does not provide a credit opinion.",
    "English summaries are provided for reference. The original Japanese source is authoritative.",
    "Possible or unresolved entity matches should be manually verified before use in a decision."
  ]
}

The original Japanese disclosure is the authoritative record. Use possible or unresolved matches only as leads for manual review.

About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.